Clinical Trial Update: The TRICURE First in Human Trial [NA]

View source ↗

Summary

TRiCares is conducting the first-in-human trial of TRICURE for tricuspid regurgitation; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• TRICURE

Snippet

Sponsor: TRiCares | Conditions: Tricuspid Regurgitation | NA | Status: ACTIVE_NOT_RECRUITING